WT
VRTX icon

Whittier Trust’s Vertex Pharmaceuticals VRTX Stock Holding History

Whittier Trust’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$795K Sell
1,830
-145
-7% -$67.6K 0.01% 381
2025
Q4 		$925K Buy
1,975
+449
+29% +$194K 0.01% 356
2025
Q3 		$615K Sell
1,526
-294
-16% -$123K 0.01% 409
2025
Q2 		$810K Sell
1,820
-104
-5% -$47.9K 0.01% 417
2025
Q1 		$933K Sell
1,924
-121
-6% -$56.4K 0.01% 384
2024
Q4 		$824K Buy
2,045
+512
+33% +$237K 0.01% 411
2024
Q3 		$713K Buy
1,533
+86
+6% +$41.3K 0.01% 438
2024
Q2 		$678K Buy
1,447
+122
+9% +$53K 0.01% 430
2024
Q1 		$554K Buy
1,325
+65
+5% +$27.5K 0.01% 472
2023
Q4 		$513K Buy
1,260
+365
+41% +$135K 0.01% 469
2023
Q3 		$311K Sell
895
-46
-5% -$16.1K 0.01% 553
2023
Q2 		$331K Sell
941
-11
-1% -$3.71K 0.01% 535
2023
Q1 		$300K Hold
952
– – 0.01% 572
2022
Q4 		$275K Sell
952
-167
-15% -$50.9K 0.01% 577
2022
Q3 		$324K Sell
1,119
-20
-2% -$5.75K 0.01% 525
2022
Q2 		$321K Sell
1,139
-14
-1% -$3.75K 0.01% 535
2022
Q1 		$301K Buy
1,153
+9
+0.8% +$2.14K 0.01% 587
2021
Q4 		$251K Buy
1,144
+224
+24% +$43.6K ﹤0.01% 627
2021
Q3 		$167K Sell
920
-40
-4% -$7.81K ﹤0.01% 675
2021
Q2 		$194K Sell
960
-70
-7% -$14.6K ﹤0.01% 660
2021
Q1 		$221K Buy
1,030
+5
+0.5% +$1.1K ﹤0.01% 621
2020
Q4 		$242K Sell
1,025
-114
-10% -$26.2K 0.01% 563
2020
Q3 		$310K Buy
1,139
+22
+2% +$6.07K 0.01% 495
2020
Q2 		$324K Buy
1,117
+139
+14% +$37.7K 0.01% 462
2020
Q1 		$232K Buy
978
+13
+1% +$2.98K 0.01% 488
2019
Q4 		$211K Sell
965
-13
-1% -$2.63K 0.01% 548
2019
Q3 		$166K Buy
978
+124
+15% +$21.9K ﹤0.01% 581
2019
Q2 		$157K Hold
854
– – ﹤0.01% 573
2019
Q1 		$157K Hold
854
– – ﹤0.01% 574
2018
Q4 		$142K Hold
854
– – ﹤0.01% 565
2018
Q3 		$165K Hold
854
– – 0.01% 538
2018
Q2 		$145K Sell
854
-137
-14% -$21.2K ﹤0.01% 558
2018
Q1 		$162K Hold
991
– – 0.01% 545
2017
Q4 		$149K Buy
991
+600
+153% +$88.8K 0.01% 551
2017
Q3 		$59K Hold
391
– – ﹤0.01% 701
2017
Q2 		$50K Hold
391
– – ﹤0.01% 707
2017
Q1 		$43K Buy
391
+137
+54% +$12.1K ﹤0.01% 736
2016
Q4 		$19K Sell
254
-60
-19% -$4.88K ﹤0.01% 887
2016
Q3 		$27K Hold
314
– – ﹤0.01% 823
2016
Q2 		$27K Hold
314
– – ﹤0.01% 840
2016
Q1 		$25K Hold
314
– – ﹤0.01% 837
2015
Q4 		$40K Hold
314
– – ﹤0.01% 759
2015
Q3 		$33K Sell
314
-120
-28% -$15.4K ﹤0.01% 779
2015
Q2 		$54K Hold
434
– – ﹤0.01% 729
2015
Q1 		$51K Buy
434
+14
+3% +$1.68K ﹤0.01% 721
2014
Q4 		$50K Hold
420
– – ﹤0.01% 652
2014
Q3 		$47K Hold
420
– – ﹤0.01% 660
2014
Q2 		$40K Hold
420
– – ﹤0.01% 679
2014
Q1 		$30K Sell
420
-330
-44% -$26.1K ﹤0.01% 737
2013
Q4 		$56K Hold
750
– – ﹤0.01% 649
2013
Q3 		$57K Hold
750
– – ﹤0.01% 644
2013
Q2 		$60K Buy
+750
New +$55.2K ﹤0.01% 626

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Whittier Trust's VRTX Position: Q1 2026 in Review

Whittier Trust reduced its Vertex Pharmaceuticals (VRTX) stake by 7.3% in Q1 2026, selling an estimated $67.6K and leaving 1,830 shares worth $795K. The position accounts for 0.01% of the portfolio, ranked #381.

Whittier Trust first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $933K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Whittier Trust held 1,830 shares of Vertex Pharmaceuticals worth $795K as of Q1 2026.
  • Whittier Trust sold 145 Vertex Pharmaceuticals shares in Q1 2026, an estimated $67.6K.
  • Vertex Pharmaceuticals made up 0.01% of Whittier Trust's portfolio in Q1 2026, its #381 holding.
  • Whittier Trust first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Whittier Trust's Vertex Pharmaceuticals position peaked at $933K in Q1 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Whittier Trust's 13F filing for Q1 2026, filed 28 Apr 2026.